文献速递肝胆胰外科

术中不可逆电穿孔切缘强化对切除胰腺癌局部复发的影响

Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer.
PubMed 文献 · Surgery · 2022-10-08

本研究比较了胰切除联合不可逆电穿孔切缘强化与单纯胰切除在临界可切除胰腺癌中的局部复发和切缘阳性率。

要点

  • 不可逆电穿孔切缘强化在IIB和III期可切除胰腺癌中安全有效。
  • 联合组切缘阳性率更高但局部复发时间与单纯切除组相同。
  • 联合组总生存期优于单纯切除组(平均34.2 vs 27.9个月)。

核心结论

  • 不可逆电穿孔切缘强化在技术上可切除的IIB和III期胰腺腺癌中安全有效。
  • 尽管切缘阳性率更高,但局部复发时间和复发影响与单纯胰切除组相同。

研究设计与样本

  • 75例接受胰切除联合不可逆电穿孔切缘强化,71例接受单纯胰切除。

主要发现

  • 联合组切缘阳性率27% vs 20%(P无显著性)。
  • 局部复发平均无病间期从诊断起联合组15.8个月 vs 单纯组16.5个月(P无显著性)。
  • 从治疗起局部复发平均时间联合组9.4个月 vs 单纯组10.5个月(P无显著性)。
  • 联合组总生存平均34.2个月 vs 单纯组27.9个月。

关键数值与推荐

  • 联合组与单纯组BMI、Charlson合并症指数和性别相似。
  • 肿瘤位置(头64% vs 72%)和肿瘤大小(中位2.9 vs 2.8)相似。
  • 新辅助/诱导化疗和既往放疗两组相似(联合组89% vs 72%)。
  • 单纯组胰十二指肠切除术比例更高。

临床怎么用

  • 对于IIB和III期临界可切除胰腺癌,可考虑胰切除联合不可逆电穿孔切缘强化以改善生存。
  • 需注意联合组切缘阳性率可能更高,但局部复发时间未见延长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to evaluate the rates of local recurrence and margin positivity in patients with borderline resectable pancreatic cancer after pancreatectomy with or without irreversible electroporation with margin accentuation. METHODS: Prospective data for preoperative stages IIB (borderline resectable) and III were evaluated, with 75 patients undergoing pancreatectomy with irreversible electroporation with margin accentuation compared to 71 patients who underwent pancreatectomy alone from March 2010 to November 2020. RESULTS: Both irreversible electroporation with margin accentuation and pancreatectomy-alone groups were similar for body mass index, Charleston comorbidity index, and sex. The irreversible electroporation with margin accentuation group had significantly greater preoperative stage III (irreversible electroporation 83% vs pancreatectomy alone 51%; P = .0001), with similar tumor location (head 64% vs 72%) and tumor size (median 2.9 vs 2.8). Neoadjuvant/induction chemotherapy and prior radiation therapy was similar in both groups (irreversible electroporation with margin accentuation 89% vs 72%). Surgical therapy included a greater percentage of pancreaticoduodenectomy in the pancreatectomy-alone group. Despite greater stage and greater percentage of margin positivity (irreversible electroporation with margin accentuation 27% vs 20%; P = not significant), rates of local recurrence were similar. The mean disease-free interval for local recurrence from time of diagnosis was similar (irreversible electroporation with margin accentuation 15.8 vs 16.5 pancreatectomy alone; P = not significant) and time of treatment (irreversible electroporation with margin accentuation 9.4 vs 10.5 months; P = not significant). Overall survival was improved with the irreversible electroporation with margin accentuation group, with a mean of 34.2 months versus 27.9 months in the pancreatectomy-alone group. CONCLUSION: Irreversible electroporation with margin accentuation is safe and effective in stages IIB and III pancreatic adenocarcinomas that are technically resectable. Despite higher margin positivity rates, the time to local recurrence and the effects of recurrence were the same in the pancreatectomy-alone group.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Martin RCG, Schoen EC, Philips P, et al. Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer. Surgery. 2022. PMID: 36216618. doi:10.1016/j.surg.2022.07.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。